Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
126,404,443
-
Total 13F shares
-
1,463,592
-
Share change
-
+651,058
-
Total reported value
-
$11,124,205
-
Price per share
-
$7.60
-
Number of holders
-
27
-
Value change
-
+$4,972,528
-
Number of buys
-
20
-
Number of sells
-
10
Institutional Holders of Organogenesis Holdings Inc. - Common Stock, $0.0001 par value per share (ORGO) as of Q2 2019
As of 30 Jun 2019,
Organogenesis Holdings Inc. - Common Stock, $0.0001 par value per share (ORGO) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,463,592 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Moors & Cabot, Inc., CHARLES SCHWAB INVESTMENT MANAGEMENT INC, NORTHERN TRUST CORP, Bank of New York Mellon Corp, NUVEEN ASSET MANAGEMENT, LLC, CITADEL ADVISORS LLC, and Assenagon Asset Management S.A..
This page lists
27
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.